Bioventus (BVS) Gross Profit (2020 - 2026)
Bioventus filings provide 6 years of Gross Profit readings, the most recent being $108.8 million for Q4 2025.
- On a quarterly basis, Gross Profit rose 5.97% to $108.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $388.2 million, a 0.02% change, with the full-year FY2025 number at $388.2 million, changed 0.02% from a year prior.
- Gross Profit hit $108.8 million in Q4 2025 for Bioventus, up from $94.2 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $108.8 million in Q4 2025 to a low of $59.6 million in Q2 2021.
- Median Gross Profit over the past 5 years was $87.0 million (2021), compared with a mean of $86.9 million.
- Biggest five-year swings in Gross Profit: soared 89.13% in 2021 and later fell 15.47% in 2022.
- Bioventus' Gross Profit stood at $87.8 million in 2021, then fell by 15.47% to $74.2 million in 2022, then increased by 16.33% to $86.3 million in 2023, then increased by 18.95% to $102.7 million in 2024, then grew by 5.97% to $108.8 million in 2025.
- The last three reported values for Gross Profit were $108.8 million (Q4 2025), $94.2 million (Q3 2025), and $102.1 million (Q2 2025) per Business Quant data.